Amal Qattan

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Venues

International journal of molecular sciences

Biomedicines

Cancers

BMC cancer

George Washington University in the United States (US)

University College London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

George Washington University in the United States (US) Jan 01 2017

United States

Assistant Professor :: School of Medicine and Health Science (SMHS)-Dep. of Biochemistry and Molecular Medicine

Education History

University College London - Mar 15 2013

United Kingdom

PHD :: Medicine

Publications

Amal Qattan, Taher Al-Tweigeri, Kausar Suleman, Wafa Alkhayal, Asma Tulbah
Advanced Insights into Competitive Endogenous RNAs (ceRNAs) Regulated Pathogenic Mechanisms in Metastatic Triple-Negative Breast Cancer (mTNBC). Cancers 16 (17) (2024)
Amal Qattan
Genomic Alterations Affecting Competitive Endogenous RNAs (ceRNAs) and Regulatory Networks (ceRNETs) with Clinical Implications in Triple-Negative Breast Cancer (TNBC). International journal of molecular sciences 25 (5) (2024)
Amal Qattan
Genomic Alterations Affecting Competitive Endogenous RNAs (ceRNAs) and Regulatory Networks (ceRNETs) with Clinical Implications in Triple-Negative Breast Cancer (TNBC). International journal of molecular sciences 25 (5) (2024)
Amal Qattan
Genomic Alterations Affecting Competitive Endogenous RNAs (ceRNAs) and Regulatory Networks (ceRNETs) with Clinical Implications in Triple-Negative Breast Cancer (TNBC). International journal of molecular sciences 25 (5) (2024)
Amal Qattan, Taher Al-Tweigeri, Kausar Suleman
Translational Implications of Dysregulated Pathways and microRNA Regulation in Quadruple-Negative Breast Cancer. Biomedicines 10 (2) (2022)
Ashraf N Abdalla, Waleed H Malki, Amal Qattan, Imran Shahid, Mohammad Akbar Hossain, Muhammad Ahmed
Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer. Molecules (Basel, Switzerland) 26 (2) (2021)
Amal Qattan, Taher Al-Tweigeri, Wafa Alkhayal, Kausar Suleman, Asma Tulbah, Suad Amer
Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis. Genes 12 (4) (2021)
Rayanah Barnawi, Samiyah Al-Khaldi, Salma Majid, Amal Qattan, Tala Bakheet, Mohannad Fallatah, Hazem Ghebeh, Nehad M Alajez, Monther Al-Alwan
Comprehensive Transcriptome and Pathway Analyses Revealed Central Role for Fascin in Promoting Triple-Negative Breast Cancer Progression. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Amal Qattan
Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease. International journal of molecular sciences 21 (23) (2020)
Amal Qattan, Haya Intabli, Wafa Alkhayal, Chafica Eltabache, Taher Tweigieri, Suad Bin Amer
Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients. BMC cancer 17 (1) (2017)

Amal Qattan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Amal Qattan